These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32247341)

  • 1. Specialty-Based Variability in Diagnosing and Managing Heart Failure With Preserved Ejection Fraction.
    Saxon DT; Kennel PJ; Guyer HM; Goyal P; Hummel SL; Konerman MC
    Mayo Clin Proc; 2020 Apr; 95(4):669-675. PubMed ID: 32247341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of treatment of patients with congestive heart failure by cardiologists versus noncardiologists.
    Patel JA; Fotis MA
    Am J Health Syst Pharm; 2005 Jan; 62(2):168-72. PubMed ID: 15700890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic impact of heart failure with preserved versus reduced ejection fraction in patients with mild symptoms].
    Jung P; Huber T; Müller M; König A; Krötz F; Sohn HY
    Dtsch Med Wochenschr; 2012 Apr; 137(14):706-10. PubMed ID: 22454198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults.
    Alagiakrishnan K; Banach M; Jones LG; Datta S; Ahmed A; Aronow WS
    Ann Med; 2013 Feb; 45(1):37-50. PubMed ID: 22413912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of structural heart disease and diastolic dysfunction in heart failure with preserved ejection fraction assessed according to the ESC guidelines - A substudy in the Ka (Karolinska) Ren (Rennes) study.
    Persson H; Donal E; Lund LH; Matan D; Oger E; Hage C; Daubert JC; Linde C;
    Int J Cardiol; 2019 Jan; 274():202-207. PubMed ID: 30049496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in heart failure with preserved ejection fraction management between care providers: an international survey.
    Guidetti F; Giraldo CIS; Shchendrygina A; Kida K; Niederseer D; Basic C; Rainer PP; Załęska-Kocięcka M; Ogola E; Mohty D; Lanfranchi G; Sari NY; Einarsson H; Zurek M; Ruschitzka F; Savarese G; Mewton N
    Eur J Heart Fail; 2024 Aug; ():. PubMed ID: 39169613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in family physicians' and cardiologists' care for patients with heart failure.
    Baker DW; Hayes RP; Massie BM; Craig CA
    Am Heart J; 1999 Nov; 138(5 Pt 1):826-34. PubMed ID: 10539812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-reported differences between cardiologists and heart failure specialists in the management of chronic heart failure.
    Bello D; Shah NB; Edep ME; Tateo IM; Massie BM
    Am Heart J; 1999 Jul; 138(1 Pt 1):100-7. PubMed ID: 10385771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care services provided during physician office visits for hypertension: differences by specialty.
    Fang J; Keenan NL; Ayala C
    J Clin Hypertens (Greenwich); 2010 Feb; 12(2):89-95. PubMed ID: 20167031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
    Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
    Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart Failure With Preserved Ejection Fraction: Current Status of Daily Clinical Practice in Indonesia.
    Nauli SE; Prima Putri VK; Arifianto H; Prameswari HS; Lubis AC; Zulkarnain E; Hasanah DY; Dewi Yamin PP; Dewi TI; Irnizarifka
    Cureus; 2023 Apr; 15(4):e38086. PubMed ID: 37257168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and Secondary Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Del Buono MG; Buckley L; Abbate A
    Am J Cardiol; 2018 Nov; 122(9):1578-1587. PubMed ID: 30220416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating heart failure in patients with diabetes: The view of the cardiologist.
    Kumowski N; Marx N; Schütt K
    Diabetes Res Clin Pract; 2021 Jun; 176():108852. PubMed ID: 33957143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure with preserved ejection fraction: A growing global epidemic.
    Naing P; Forrester D; Kangaharan N; Muthumala A; Mon Myint S; Playford D
    Aust J Gen Pract; 2019 Jul; 48(7):465-471. PubMed ID: 31256507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and therapeutic challenges for PCPs regarding heart failure with preserved ejection fraction and obesity: results of an online internet-based survey.
    Campos C; Magwire M; Butler J; Hoovler A; Sabharwal A; Shah SJ
    BMC Prim Care; 2024 Aug; 25(1):288. PubMed ID: 39118004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic management of heart failure with preserved ejection fraction.
    Huang D; Cheng JW
    Ann Pharmacother; 2010 Dec; 44(12):1933-45. PubMed ID: 21098754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsatile hemodynamics in patients with exertional dyspnea: potentially of value in the diagnostic evaluation of suspected heart failure with preserved ejection fraction.
    Weber T; Wassertheurer S; O'Rourke MF; Haiden A; Zweiker R; Rammer M; Hametner B; Eber B
    J Am Coll Cardiol; 2013 May; 61(18):1874-83. PubMed ID: 23500307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
    Solomon SD; Rizkala AR; Lefkowitz MP; Shi VC; Gong J; Anavekar N; Anker SD; Arango JL; Arenas JL; Atar D; Ben-Gal T; Boytsov SA; Chen CH; Chopra VK; Cleland J; Comin-Colet J; Duengen HD; Echeverría Correa LE; Filippatos G; Flammer AJ; Galinier M; Godoy A; Goncalvesova E; Janssens S; Katova T; Køber L; Lelonek M; Linssen G; Lund LH; O'Meara E; Merkely B; Milicic D; Oh BH; Perrone SV; Ranjith N; Saito Y; Saraiva JF; Shah S; Seferovic PM; Senni M; Sibulo AS; Sim D; Sweitzer NK; Taurio J; Vinereanu D; Vrtovec B; Widimský J; Yilmaz MB; Zhou J; Zweiker R; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV
    Circ Heart Fail; 2018 Jul; 11(7):e004962. PubMed ID: 29980595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.